Susan M Chang

发表

End point assessment in gliomas: novel treatments limit usefulness of classical Macdonald's Criteria.

Patrick Y Wen, Susan M. Chang, Michael A Vogelbaum, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

CONVECTION‐ENHANCED DELIVERY OF CINTREDEKIN BESUDOTOX (INTERLEUKIN‐13‐PE38QQR) FOLLOWED BY RADIATION THERAPY WITH AND WITHOUT TEMOZOLOMIDE IN NEWLY DIAGNOSED MALIGNANT GLIOMAS: PHASE 1 STUDY OF FINAL SAFETY RESULTS

Raj K Puri, Susan M. Chang, Michael A Vogelbaum, 2007, Neurosurgery.

3D sensitivity encoded ellipsoidal MR spectroscopic imaging of gliomas at 3T.

Esin Ozturk-Isik, Daniel B Vigneron, Duan Xu, 2009, Magnetic resonance imaging.

Epidermal growth factor receptor variant III status defines clinically distinct subtypes of glioblastoma.

Li Zhang, Howard Colman, Dima Suki, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Characterization of metabolites in infiltrating gliomas using ex vivo 1H high-resolution magic angle spinning spectroscopy

Annette M Molinaro, Alexandra Constantin, Susan M. Chang, 2014, NMR in biomedicine.

Clinical trial design for systemic agents in patients with brain metastases from solid tumours: a guideline by the Response Assessment in Neuro-Oncology Brain Metastases working group.

Eudocia Q Lee, Martin Bendszus, Gordon J Harris, 2018, The Lancet. Oncology.

Proton magnetic resonance spectroscopy imaging in the evaluation of patients undergoing gamma knife surgery for Grade IV glioma.

Susan M. Chang, Sarah J Nelson, William P Dillon, 2004, Journal of neurosurgery.

Patterns of recurrence analysis in newly diagnosed glioblastoma multiforme after three-dimensional conformal radiation therapy with respect to pre-radiation therapy magnetic resonance spectroscopic findings.

Ilwoo Park, Mitchel S Berger, Susan M. Chang, 2007, International journal of radiation oncology, biology, physics.

MRI apparent diffusion coefficient reflects histopathologic subtype, axonal disruption, and tumor fraction in diffuse-type grade II gliomas.

Inas S. Khayal, Soonmee Cha, Susan M. Chang, 2011, Neuro-oncology.

Targeting iron metabolism in high-grade glioma with 68Ga-citrate PET/MR.

Youngho Seo, Yan Li, Soonmee Cha, 2018, JCI insight.

7-Tesla susceptibility-weighted imaging to assess the effects of radiotherapy on normal-appearing brain in patients with glioma.

Christopher P Hess, Susan M. Chang, Cynthia F Chuang, 2012, International journal of radiation oncology, biology, physics.

Comparison between 8‐ and 32‐channel phased‐array receive coils for in vivo hyperpolarized 13C imaging of the human brain

Azma Mareyam, Lawrence L Wald, Ilwoo Park, 2019, Magnetic resonance in medicine.

Temozolomide-associated hypermutation in gliomas.

Susan M. Chang, J. Costello, Serah Choi, 2018, Neuro-oncology.

Perioperative complications and neurological outcomes of first and second craniotomies among patients enrolled in the Glioma Outcome Project.

Wei Huang, Mark Bernstein, Henry Brem, 2003, Journal of neurosurgery.

Partial‐volume model for determining white matter and gray matter cerebral blood volume for analysis of gliomas

Soonmee Cha, Susan M. Chang, Sarah J Nelson, 2006, Journal of magnetic resonance imaging : JMRI.

Volumetric extent of resection and residual contrast enhancement on initial surgery as predictors of outcome in adult patients with hemispheric anaplastic astrocytoma.

Tarik Tihan, Mitchel S Berger, Edward F Chang, 2006, Journal of neurosurgery.

Adaptive Global Innovative Learning Environment for Glioblastoma: GBM AGILE

Brian M Alexander, Mitchel S Berger, Timothy F Cloughesy, 2017, Clinical Cancer Research.

Short‐echo three‐dimensional H‐1 MR spectroscopic imaging of patients with glioma at 7 tesla for characterization of differences in metabolite levels

Eugene Ozhinsky, Yan Li, Peder Larson, 2015, Journal of magnetic resonance imaging : JMRI.

Regional variation in histopathologic features of tumor specimens from treatment-naive glioblastoma correlates with anatomic and physiologic MR Imaging.

Mitchel S Berger, Soonmee Cha, Susan M. Chang, 2012, Neuro-oncology.

Seizure characteristics and control following resection in 332 patients with low-grade gliomas.

Mitchel S Berger, Edward F Chang, Susan M. Chang, 2008, Journal of neurosurgery.

Clinical trial end points for high-grade glioma: the evolving landscape.

Timothy F Cloughesy, Mark R Gilbert, Wolfgang Wick, 2011, Neuro-oncology.

Assessment of perfusion MRI-derived parameters in evaluating and predicting response to antiangiogenic therapy in patients with newly diagnosed glioblastoma.

Mei-Yin Polley, Soonmee Cha, Susan M. Chang, 2011, Neuro-oncology.

Direct intracerebral delivery of cintredekin besudotox (IL13-PE38QQR) in recurrent malignant glioma: a report by the Cintredekin Besudotox Intraparenchymal Study Group.

Mitchel S Berger, Raj K Puri, Susan M. Chang, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

GRAPPA-based susceptibility-weighted imaging of normal volunteers and patients with brain tumor at 7 T.

Sharmila Majumdar, Daniel B Vigneron, Duan Xu, 2009, Magnetic resonance imaging.

Temozolomide in the treatment of recurrent malignant glioma

Susan M. Chang, M. Prados, P. Theodosopoulos, 2004, Cancer.

Differential sensitivity of glioma- versus lung cancer-specific EGFR mutations to EGFR kinase inhibitors.

Paul S Mischel, Steve Horvath, Timothy F Cloughesy, 2012, Cancer discovery.

DNA Methylation and Somatic Mutations Converge on the Cell Cycle and Define Similar Evolutionary Histories in Brain Tumors.

Chibo Hong, Aleksandr Pankov, Jun S. Song, 2015, Cancer cell.

Neuroimaging: diagnosis and response assessment in glioblastoma.

Susan M. Chang, Jennifer L. Clarke, Susan M Chang, 2012, Cancer journal.

Toward precision medicine in glioblastoma: the promise and the challenges.

Timothy C Ryken, Timothy F Cloughesy, Annette M Molinaro, 2015, Neuro-oncology.

The phenotypes of proliferating glioblastoma cells reside on a single axis of variation.

Arnold Kriegstein, Harsh Wadhwa, Francisca Catalan, 2019, Cancer discovery.

Application of Novel Response/Progression Measures for Surgically Delivered Therapies for Gliomas: Response Assessment in Neuro-Oncology (RANO) Working Group

Patrick Y Wen, Susan M. Chang, Michael A Vogelbaum, 2012, Neurosurgery.

Functional mapping-guided resection of low-grade gliomas in eloquent areas of the brain: improvement of long-term survival. Clinical article.

Mitchel S Berger, Edward F Chang, Mei-Yin Polley, 2011, Journal of neurosurgery.

Progression-free survival: an important end point in evaluating therapy for recurrent high-grade gliomas.

Timothy F Cloughesy, Mark R Gilbert, Patrick Y Wen, 2008, Neuro-oncology.

Safety of intraparenchymal convection-enhanced delivery of cintredekin besudotox in early-phase studies.

Mitchel S Berger, Christoph Pedain, Raj K Puri, 2006, Neurosurgical focus.

Prognostic significance of intracranial dissemination of glioblastoma multiforme in adults.

Mitchel S Berger, Susan M. Chang, M. Berger, 2005, Journal of neurosurgery.

Automated prescription of oblique brain 3D magnetic resonance spectroscopic imaging

Eugene Ozhinsky, Daniel B Vigneron, Susan M. Chang, 2013, Magnetic resonance in medicine.

Evaluation of diffusion parameters as early biomarkers of disease progression in glioblastoma multiforme.

Inas S. Khayal, Soonmee Cha, Susan M. Chang, 2010, Neuro-oncology.

Serial analysis of 3D H-1 MRSI for patients with newly diagnosed GBM treated with combination therapy that includes bevacizumab

Yan Li, Soonmee Cha, Susan M. Chang, 2016, Journal of Neuro-Oncology.

Multiinstitutional validation of the University of California at San Francisco Low-Grade Glioma Prognostic Scoring System. Clinical article.

Mark Bernstein, Mitchel S Berger, Edward F Chang, 2009, Journal of neurosurgery.